Toxoplasma gondii lacks the capacity to synthesize purines de novo, and ade
nosine kinase (AK)-mediated phosphorylation of salvaged adenosine provides
the major route of purine acquisition by this parasite. T. gondii AK thus r
epresents a promising target for rational design of antiparasitic compounds
. In order to further our understanding of this therapeutically relevant en
zyme, an AK cDNA from T. gondii was overexpressed in E. coil using the pBAc
e expression system, and the recombinant protein was purified to apparent h
omogeneity using conventional protein purification techniques. Kinetic anal
ysis of TgAK revealed K-m values of 1.9 mu M for adenosine and 54.4 mu M fo
r ATP, with a k(cat) of 26.1 min(-1). Other naturally occurring purine nucl
eosides, nucleobases, and ribose did not significantly inhibit adenosine ph
osphorylation. but inhibition was observed using certain purine nucleoside
analogs. Adenine arabinoside (AraA), 4-nitrobenzylthioinosine (NBMPR), and
7-deazaadenosine (tubercidin) were all shown to be substrates of T. gondii
AK. Transgenic AK knock-out parasites were resistant to these compounds in
cell culture assays, consistent with their proposed action as subversive su
bstrates in vivo. (C) 1999 Elsevier Science B.V. All rights reserved.